<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Post-transplant <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> (PTLD) biopsy material is rarely available in adequate quantity for research </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, the present study was designed to expand biopsy material in scid mice </plain></SENT>
<SENT sid="2" pm="."><plain>Epstein-Barr virus (EBV)+ve PTLD samples from five transplant patients were established in scid mice </plain></SENT>
<SENT sid="3" pm="."><plain>PCR analysis of immunoglobulin gene rearrangements demonstrated that four of the five biopsies (80%) gave rise to scid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> which represented the original <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell clones </plain></SENT>
<SENT sid="4" pm="."><plain>Immunophenotyping showed that these four biopsies (and <z:hpo ids='HP_0000001'>all</z:hpo> scid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>) expressed <z:hpo ids='HP_0000001'>all</z:hpo> EBV latent genes and a B lymphoblast phenotype; &lt;or=26% T cells were found in the biopsy material whereas scid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> showed a paucity of T lymphocytes </plain></SENT>
<SENT sid="5" pm="."><plain>RT-PCR analysis revealed expression of IL-2, -4, -6, -10 and IFN-gamma in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> material, suggesting key roles for these factors in <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The results show that EBV+ve PTLD material can be expanded in scid mice giving rise to quantities of homogeneous malignant tissue sufficient for research studies </plain></SENT>
</text></document>